Radiotherapy (RT) has been shown to trigger immunogenic cell death with HMGB1 (High Mobility Group Box 1) release by tumor cells and dendritic cells (DCs) activation through TLR4, allowing a tumor antigen-specific T cell immunity [16]. Here, HMGB1 is linked to neoplasm.